Uwe Schoenbeck (L) and Julie Grant

Canaan adds $100M+ to boost bio­phar­ma in­vest­ing, brings on for­mer Pfiz­er ex­ec

Canaan, a decades-old tech and life sci­ences ven­ture cap­i­tal firm, plans to in­vest more heav­i­ly in bio­phar­ma go­ing for­ward.

The Men­lo Park, CA-based firm added …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.